Longevity medicine in China has moved from experimental to institutional. The same cellular health assessments, biological-age testing, and physician-led longevity protocols available in premium Swiss clinics are now offered in China — backed by Grade 3A public hospitals, a dedicated Hainan medical zone, and Clinique La Prairie's first health resort outside Europe, all at significantly lower cost.
China is one of the few places where you can access the complete arc of longevity medicine: a $130 biological-age screening on a Tuesday, a $15,000 week-long immersive longevity program in Anji's bamboo forests on the weekend, and — for specific indications — licensed cell or gene therapy in Hainan's Boao Lecheng pilot zone. This range is not available as a single destination anywhere else in Asia.
Three structural advantages make China stand out. First, regulatory velocity: Hainan's "special medical needs" pathway has approved 29 cell and gene therapy technologies since 2025 (as of March 2026), with prices published and administered inside JCI-standard facilities. Second, institutional depth: Fudan Zhongshan Hospital and other Grade 3A centers run dedicated aging and preventive-medicine research programs, so your assessment is physician-led, not sales-led. Third, cost structure: without the Swiss franc premium, European resort prices, or US facility fees, the same diagnostics and protocols cost 40–75% less.
The result is a destination where longevity medicine is serious, measurable, and accessible — from prevention-first travelers who want one deep assessment to high-net-worth patients seeking a full physician-led longevity program.
Longevity medicine is the clinical practice of slowing biological aging and reducing age-related disease risk through objective biomarkers. It starts with testing — epigenetic clocks, inflammatory markers, metabolic panels, body composition, vascular health, and hormonal status — then builds a protocol around what the data actually shows.
A credible program has four parts: measure (baseline biological age and risk factors), intervene (nutrition, movement, targeted supplementation, hormone optimization, and — where clinically indicated — licensed cell therapy at pilot-zone hospitals), monitor (repeat biomarkers to verify change), and maintain (a take-home plan you can follow anywhere). Anything that skips measurement and jumps straight to treatment is not longevity medicine — it is marketing.
In China, this discipline sits inside real medical institutions. Fudan University's Zhongshan Hospital runs clinical research on aging and chronic disease; Shanghai's premium clinics operate under Mayo Clinic guidance; and Boao Lecheng's licensed therapies are administered in hospital-grade facilities. That clinical backbone is what separates China's longevity offering from wellness tourism.
Each pathway serves a different goal and budget. We help you choose the right level — and often combine two (for example, a Shanghai assessment + Anji reset).
Swiss longevity brand since 1931. Asia's first CLP Health Resort, opened April 2024 among bamboo forests and white-tea fields. Full CLP Longevity Method™ programs: medical diagnostics, cellular health, nutrition, movement, sleep, and mental wellbeing.
Mayo Clinic Care Network member. Preventive health and biological-age assessments, executive longevity screening, hormone optimization, and personalized lifestyle protocols — delivered in a private, full-service clinic setting.
Assessment pricing only — the cost of any personalized treatment program is quoted after the clinic's in-person medical evaluation.
National top-ranked general medicine. Aging and preventive-medicine research programs, biological-age testing, chronic-disease risk screening, and integrated prevention programs. Ideal for patients who want hospital-grade diagnostics before any intervention.
Diagnostics and screening only, priced before any intervention — a personalized treatment plan and its cost are determined after the hospital's medical evaluation.
Licensed cell and gene therapies for specific disease indications — joint repair, immune modulation, metabolic disease. Anti-aging alone is not an approved indication; eligibility requires a diagnosed condition. Prices published by Hainan authorities; procedures administered in regulated pilot-zone hospitals.
| Program | Best for | Typical price range | Time needed |
|---|---|---|---|
CLP Anji |
High-net-worth reset / immersive resort program | $15,000 – $32,000 | 7 days / 6 nights |
Shanghai premium clinic |
Annual assessment / prevention-first plan | $130 – $1,500 (assessment only) | 1 half-day |
Fudan Zhongshan Hospital |
Hospital-grade diagnostics before intervention | $200 – $1,200 (diagnostics only) | 1 day |
Boao Lecheng |
Specific indication eligible for cell/gene therapy | $2,200 – $66,200 | 3–14 days |
Prices cover the full spectrum, from a single assessment to a full immersive program. China figures reflect international-department and private-hospital rates — the channel international patients actually use — not local public-department rates. All figures are self-pay and include medical coordination; flights and accommodation are separate unless noted.
| Service | Overseas benchmark | China | Indicative savings |
|---|---|---|---|
Biological-age / longevity screening |
$800 – $2,500 | $500 – $1,500 | 35–50% |
Executive longevity checkup (full-day) |
$3,000 – $8,000 | $1,500 – $4,500 | 40–55% |
7-day immersive longevity resort program |
$50,000 – $100,000 | $15,000 – $32,000 | 55–75% |
Cell / gene therapy (eligible indications) |
Not broadly available or $80,000+ | $2,200 – $66,200 | Significant, indication-dependent |
Programs vary by level, but the clinical core is consistent: measurement first, protocol second, verification third.
Epigenetic age, inflammatory markers (CRP, IL-6), metabolic panel, lipids, hormones, thyroid, vitamin D, gut health indicators, and body composition.
Carotid intima-media thickness, arterial stiffness, ECG, echocardiogram, and where indicated coronary calcium scoring — hospital-grade, not spa-grade.
Telomere length, NAD+ status, mitochondrial function markers, oxidative stress, and immune-cell profiling — the biological-age picture.
A doctor-designed intervention plan: nutrition, movement, sleep, targeted supplementation, and referral to licensed pilot-zone cell-therapy pathways when an approved indication applies.
Since 2025, Hainan's Boao Lecheng Medical Tourism Pilot Zone has published successive batches of approved cell and gene therapies — 29 technologies as of March 2026, each tied to a specific disease indication and administered inside designated hospitals. The legal basis is the zone's 2024 Biomedical New Technology Regulation, China's first local statute licensing clinical application of cell and gene therapy, with prices filed and published. Cell and gene therapy is moving from gray-market speculation into supervised, priced, trackable care — inside the pilot zone only.
Examples include anti-EBV cell therapy (≈$2,200), stem-cell therapy for liver cirrhosis and rheumatoid arthritis, and ovarian-function restoration protocols. In April 2026, a 73-year-old Canadian patient became the first international patient to complete an approved stem-cell program for type 2 diabetes at Ciming Boao International Hospital — a ¥174,000 (≈$24,000) three-infusion protocol. Note that anti-aging itself is not an approved indication: every therapy targets a diagnosed condition, and treatment is available only at designated hospitals inside the pilot zone — not elsewhere in mainland China.
We do not oversell these therapies — eligibility is indication-specific, and outcomes vary by individual. Our role is to help you understand whether you are a candidate, what the evidence says, and how to access treatment safely. Read the full Boao Lecheng guide →
Boao Super Hospital, Boao Lecheng International Medical Tourism Pilot Zone · Photo: Wikimedia Commons, CC BY-SA 4.0
Honest answers about safety, evidence, cost, and what to expect.
Legitimate — when you choose the right setting. Hospital-based programs (Fudan Zhongshan, Grade 3A centers) and licensed resort medical programs (CLP Anji) are physician-led and measurement-driven. The warning signs of marketing over medicine are easy to spot: no baseline testing, no follow-up biomarkers, vague "anti-aging" claims, and pressure to buy packages on the spot. We only work with institutions that document before-and-after biomarkers and tie protocols to clinical data.
Same brand, same CLP Longevity Method™, lower cost. CLP Anji applies the same medical framework — diagnostics, nutrition, movement, sleep, cellular health, mental wellbeing — in a 7-day immersive format. Because it is in China, the program typically costs 40–60% less than the Swiss flagship for a comparable week-long experience. The Anji location also adds a unique environment: white-tea fields, bamboo forests, and a resort designed around recovery.
Cell and gene therapies in Boao Lecheng are approved for specific indications — not general "anti-aging." Good candidates typically have a documented condition such as moderate joint degeneration, certain autoimmune or metabolic conditions, liver cirrhosis, or post-cancer immune recovery. The first step is a medical review of your records; if your indication is not on the approved list, we will tell you honestly and suggest alternative pathways.
No. CLP Anji, Shanghai premium clinics, and Boao Lecheng's international departments all provide English-speaking medical coordinators and translated reports. For complex consultations, we provide professional medical interpretation in English, Russian, Arabic, and Spanish. Your medical records and treatment plan are delivered in English.
A Shanghai or Zhongshan assessment can be completed in one day. CLP Anji programs run 7 days / 6 nights. Boao Lecheng therapies range from 3 to 14 days depending on the protocol. Many patients combine programs: assessment in Shanghai on arrival, followed by an immersive program in Anji or therapy in Hainan. We coordinate the full itinerary.
No ethical medical program can guarantee results. What we can guarantee is process: hospital-standard diagnostics, physician oversight, transparent pricing, and repeat biomarkers so you can see whether your biological markers are moving in the right direction. We set realistic expectations up front and decline cases where we believe the expected benefit does not justify the cost or travel.
Start with a free consultation. Share your age, health goals, recent medical history, and any prior biomarker tests. Within 48 hours, our medical coordinator will recommend the right pathway — whether that is a $130 assessment, a $15,000 resort program, or no trip at all if China is not the best fit for your situation.
Many patients stack services into one China trip — a longevity assessment, a full health checkup, or TCM recovery support.
Add a comprehensive screening to your longevity trip — catch issues before they become conditions.
Acupuncture, tuina, and herbal support for recovery, sleep, and immune regulation after an intensive program.
The full picture on Hainan's pilot zone: approved therapies, prices, policies, and how to access them.
Visa, flights, accommodation near medical facilities, and how we coordinate your full itinerary.
The science behind biological age, and what a premium longevity checkup actually measures.
Longevity medicine goes beyond cosmetic anti-aging: measurable biomarkers, physician-led programs and repeatable outcomes. Here is how the field works — and what Clinique La Prairie's Anji resort brings to it.
Glycan age, epigenetic clocks, ceramide scores — the numbers behind your biological age, what they mean, and how often you should re-test.
Low-dose CT, 3T MRI, endoscopy, cardiac screening and a same-day specialist review — inside a one-day executive checkup at China's top international departments.
Tell us your goals, age range, and any prior biomarker tests. Within 48 hours, we will recommend the right clinic and program level — and tell you honestly if China is not the best fit.
Share your goals and we will respond within 48 hours.